Holding my own with NBRI anyway thx...
'Recharging thye batteries" is good...
With VRAL...that's not to say there isn't still a lot of $$ to be made there...especially if/when their algae tech passes trials &/or their therapeutics go into IND trials....both are Big deals & both are very likely to happen.
The difference now though is that nasty SS , cutting any possible gains by 50% (at best). I checked-out many of their peer micro-cap pharma competitors & most have an O/S of 50 to 150M...VRAL is now at 1.5B...BIG difference.The only pharma's with a SS in the billions are the mega-corps. When they realize the error of their ways (preventing their advance to a higher exchange), I highly suspect a 1:100 (or more) R/S to be in their future.
Hence...this has turned into a 'trade' for me instead of the longterm 'hold' it should have been...back to the 'hunt' for me.
GL2us
.
Market Data 
Markets 
AI
